Cipla launches daptomycin for injection, 500 mg/vial
The single-dose vials are for intravenous use only
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Agilent introduces intelligent LC/MS system for chromatographers in India
The intuitive quadrupole incorporates 'designed-in' smart features
Eisai India and Mylan to commercialise teceris
The second eribulin brand in India, teceris aimed at expanding access to metastatic breast cancer patients in India
Lupin gets 3 observations from USFDA for its Tarapur facility
The inspection of Tarapur facility was carried out by the United States Food and Drug administration (USFDA) between September…
Price caps are a band aid hiding larger issues
Pharma companies should not be the ones held responsible for the high prices of medicines
MyMedicineBox collaborates with Paytm First to help chronic patients
The service includes great savings upto 60 per cent on various needs of patients
USV to invest Rs 4,000 mn in new formulation plant at Vadodara
USV has three plants based in Daman and Baddi manufacturing tablets, capsules, sterile injectables and ophthalmic products, one…
Lupin appoints Jon Stelzmiller as President of US Specialty Business
He brings to Lupin over 30 years of experience in the specialty segment, and will be replacing Nicholas Hart
Cipla announces closure of USFDA inspection at Bengaluru facility
Following an inspection by USFDA at the company’s API manufacturing facility in Virgonagar, from July 15 to 19, the company has…
First patient randomised in a Phase 2A, Proof of Concept (PoC) clinical trial of SUVN-G3031
The trial is taking place for the treatment of Narcolepsy associated with or without Cataplexy in USA